Compare KSS & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KSS | BHC |
|---|---|---|
| Founded | 1962 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.3B |
| IPO Year | 1995 | 1996 |
| Metric | KSS | BHC |
|---|---|---|
| Price | $22.95 | $8.14 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 13 | 7 |
| Target Price | ★ $19.21 | $8.00 |
| AVG Volume (30 Days) | ★ 4.0M | 3.7M |
| Earning Date | 11-24-2026 | 10-28-2026 |
| Dividend Yield | ★ 2.09% | N/A |
| EPS Growth | 142.86 | ★ 423.08 |
| EPS | ★ 1.18 | N/A |
| Revenue | N/A | ★ $8,724,000,000.00 |
| Revenue This Year | N/A | $7.07 |
| Revenue Next Year | $0.09 | N/A |
| P/E Ratio | $21.23 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.38 | $4.33 |
| 52 Week High | $25.43 | $9.04 |
| Indicator | KSS | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 54.64 | 66.04 |
| Support Level | $15.98 | $5.49 |
| Resistance Level | $25.10 | N/A |
| Average True Range (ATR) | 1.21 | 0.42 |
| MACD | -0.14 | 0.13 |
| Stochastic Oscillator | 44.87 | 67.42 |
Kohl's is the second-largest traditional US department store company by sales. It has about 1,150 stores in 49 states and offers moderately priced private-label (31% of 2025 sales) and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most (about 80%) of its stores are in strip centers. Kohl's also has a large digital sales operation (29% of 2025 sales). Women's apparel is the retailer's largest category, having generated 24% of its 2025 sales. Kohl's is headquartered in Menomonee Falls, Wisconsin, and was founded in 1962.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.